Unusual presentation of hepatitis B serological markers in an Amerindian community of Venezuela with a majority of occult cases

Virology Journal

Volumn 8, Issue , 2011, Pages

  Cardona, Nathalia E ^a   Loureiro, Carmen L ^b   Garzaro, Domingo J ^b   Duarte, María C ^a   García, Daisy M ^a   Pacheco, Milian C ^a   Chemin, Isabelle ^c   Pujol, Flor H ^b  

^a Centro Amazánico Para la Investigacián y Control de Enfermedades Tropicales   (Venezuela)

^b Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Amerindians; Hepatitis B virus; Occult infection

Indexed keywords

CORE PROTEIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

AMERICAN INDIAN; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; SEQUENCE ANALYSIS; SEROLOGY; STOP CODON; VENEZUELA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PREVALENCE; VENEZUELA;

HEPATITIS B VIRUS;

EID: 83055187821     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-527     Document Type: Article

References (22)

1. Hepatitis B virus genetic diversity in Latin America. Devesa M, Pujol FH, Virus Res 2007 127 177 184 10.1016/j.virusres.2007.01.004 17280734 (Pubitemid 47064410)
2. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela. Duarte MC, Cardona N, Poblete F, González K, García M, Pacheco M, Botto C, Pujol FH, Williams JR, Trop Med Int Health 2010 15 924 933 10.1111/j.1365-3156.2010.02560.x 20561309
3. An overview of occult hepatitis B virus infection. Said ZN, World J Gastroenterol 2011 17 1927 1938 10.3748/wjg.v17.i15.1927 21528070
4. Occult hepatitis B virus infection: a covert operation. Hollinger FB, Sood G, J Viral Hepat 2010 17 1 15 20002296
5. Management of occult hepatitis B virus infection: an update for the clinician. Lledá JL, Fernández C, Gutiérrez ML, Ocãa S, World J Gastroenterol 2011 17 1563 1568 10.3748/wjg.v17.i12.1563 21472122
6. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D. Owiredu WK, Kramvis A, Kew MC, J Med Virol 2001 64 441 454 10.1002/jmv.1070 11468728 (Pubitemid 32613730)
7. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. Roman S, Tanaka Y, Khan A, Kurbanov F, Kato H, Mizokami M, Panduro A, J Med Virol 2010 82 1527 1536 10.1002/jmv.21846 20648606
8. Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. Devesa M, Loureiro CL, Rivas Y, Monsalve F, Cardona N, Duarte MC, Poblete F, Gutierrez MF, Botto C, Pujol FH, J Med Virol 2008 80 20 26 10.1002/jmv.21024 18041024 (Pubitemid 350220085)
9. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. Gutiérrez C, Devesa M, Loureiro CL, Leán G, Liprandi F, Pujol FH, J Med Virol 2004 73 200 207 10.1002/jmv.20076 15122793 (Pubitemid 38542673)
10. Occult hepatitis B virus infection in a North American community-based population. Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B, Giulivi A, J Hepatol 2005 42 480 485 10.1016/j.jhep.2004.11.037 15763333 (Pubitemid 40342925)
11. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. Martin CM, Welge JA, Shire NJ, Rouster SD, Shata MT, Sherman KE, Blackard JT, J Viral Hepat 2010 17 588 597 19889143
12. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM, J Clin Virol 2006 35 14 20 10.1016/j.jcv.2005.04.003 15916918 (Pubitemid 43020947)
13. Occult hepatitis B virus infection: a complex entity with relevant clinical implications. Larrubia JR, World J Gastroenterol 2011 17 1529 1530 10.3748/wjg.v17.i12.1529 21472115
14. Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Reina-San-Martin B, Cosson A, Minoprio P, Parasitol Today 2000 16 62 67 10.1016/S0169-4758(99)01591-4 10652489 (Pubitemid 30089097)
15. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A, HepaICONA and the ICONA Study Groups, Infection 2009 37 445 449 10.1007/s15010-008-8194-9 19669092
16. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey. Pinarbasi B, Onel D, Cosan F, Akyuz F, Dirlik N, Cakaloglu Y, Badur S, Besisik F, Demir K, Okten A, Kaymakoglu S, Liver Int 2009 29 227 230 10.1111/j.1478-3231.2008.01809.x 18662283
17. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. Weinberger KM, Bauer T, Böhm S, Jilg W, J Gen Virol 2000 81 1165 1174 10769057 (Pubitemid 30232700)
18. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection. Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Houspie L, Verbeeck J, Rahman M, Maes P, Vanwijngaerden E, Nevens F, Van Ranst M, J Med Virol 2011 83 1876 1884 10.1002/jmv.22174 21915860
19. Evolution of Hepatitis B and C serum markers: a still challenging issue. Chemin I, Trépo C, Liver Int 2011 31 905 907 10.1111/j.1478-3231.2011. 02479.x 21733079
20. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Shi Y, Wu YH, Wei W, Zhang WJ, Yang J, Chen Z, Liver Int 2001
21. Clinical impact of occult HBV infections. Chemin I, Trépo C, J Clin Virol 2005 34 15 S21 16461218
22. HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors. Pereira JS, Gonçales NS, Silva C, Lazarini MS, Pavan MH, Fais VC, Gonçales FL Jr, Braz J Med Biol Res 2006 39 525 531 16612476